Articles
New Arrival - Creatine for women. Shop now!
Jump to:
Iron bisglycinate is a chelated form of iron bound to two glycine molecules. Ferrous sulfate is an inorganic iron salt. Published research shows iron bisglycinate is comparably effective at lower elemental doses (18–25mg vs 50–105mg), with significantly fewer gastrointestinal side effects, better absorption when taken with food, and higher adherence in pregnancy. Ferrous sulfate remains cheaper and more widely prescribed, and is suitable for women who tolerate it.
If you've ever been prescribed iron and quietly stopped taking it because of how it made you feel, you're in good company — and you weren't being non-compliant. You were being human.
A 2015 meta-analysis of 43 randomised controlled trials in over 6,800 adults found that ferrous sulfate — still the most prescribed oral iron worldwide — more than doubles the odds of gastrointestinal side effects compared to placebo. In real-world prescribing studies, a significant proportion of people prescribed oral iron don't complete their course. The reasons cluster around gut symptoms.
What most women aren't told in the short window of a GP appointment is that the side effects are tied less to iron itself than to the form of iron being used. Different forms of iron behave very differently in the gut. The molecule on your label matters at least as much as the milligrams on your label.
The difference between iron bisglycinate and ferrous sulfate isn't a marketing preference. It's a difference in chemistry, in how the molecule moves through the digestive tract, and — for many women — a difference in whether they'll still be taking the supplement three months from now.
This is the comparison I wish every woman starting iron supplementation had access to before she gave up on iron altogether.
Ferrous sulfate is the workhorse of iron supplementation worldwide. It's on the WHO Essential Medicines List, has been used clinically for over a century, and is the iron form behind familiar Australian products like Ferro-grad C, Ferro-Liquid, and FAB Iron. Most ferrous sulfate prescriptions in Australia deliver between 65mg and 105mg of elemental iron per tablet.
It's also the iron form with the largest body of research behind it. When clinical trials need a benchmark, ferrous sulfate is almost always the comparator. That is a genuine strength — its behaviour is well characterised.
The reason it has dominated for so long is straightforward. It is cheap to manufacture, shelf-stable, and prescribers are deeply familiar with it. From a public-health perspective, it has been the default option for a long time.
The question that has come into sharper focus over the last decade is what happens between the tablet and the absorbed iron.
Ferrous sulfate dissociates in the acidic environment of the stomach into free ferrous (Fe2+) ions. Free iron is highly reactive — research shows it generates reactive oxygen species in the gut lumen, which can affect the intestinal mucosa, alter motility, and shift the balance of gut bacteria. At typical absorption rates of around 10–15%, the unabsorbed fraction is large, and that unabsorbed iron continues to oxidise as it moves through the gut.
This is the mechanism researchers point to as the source of the symptom profile most women know: constipation, nausea, abdominal cramping, the metallic taste, the dark stools. The Tolkien meta-analysis found ferrous sulfate roughly doubled the odds of GI side effects versus placebo and tripled them versus IV iron, and notably found no relationship between sulfate dose and side-effect frequency. In other words, lowering the dose of ferrous sulfate doesn't reliably solve the tolerability problem — the molecule does.
A second issue is dietary interaction. Ferrous sulfate's absorption is highly sensitive to calcium, the polyphenols in tea and coffee, the phytates in wholegrains, and the tannins in red wine. Practically, this means ferrous sulfate is often recommended on an empty stomach to absorb well — which tends to make any nausea worse — or with food, which reduces absorption. [INTERNAL LINK: ferritin levels in Australian women — what's optimal] walks through how this plays out in real ferritin numbers.
It is a cheap, well-studied iron form that a significant proportion of women cannot tolerate. Both of those things are true.
Iron bisglycinate — sometimes called ferrous bisglycinate or chelated iron, and often branded as Ferrochel® in clinical research — is a different chemical entity altogether. Each iron atom is covalently bonded to two molecules of the amino acid glycine. That bond is the entire story.
Because the iron is held inside a stable amino acid chelate, it does not dissociate into free ferrous ions in the stomach the way ferrous sulfate does. It travels through the gut as an intact molecule and is absorbed largely through amino acid transporters in the small intestine, in addition to the DMT-1 pathway that ferrous salts rely on.
Three things follow from that.
First, the iron is shielded from the gut lining for most of its journey. There is far less free iron in the mucosal environment, which is the mechanism researchers credit for the consistently lower GI side-effect rates in clinical trials. A 2024 randomised study comparing equipotent doses of bisglycinate, ferrous fumarate, and ferrous sulfate in pregnant women found ferrous bisglycinate 25mg had the most favourable GI side-effect profile of the three, with the lowest rate of black stools (8% vs 22% for fumarate and 31% for sulfate).
Second, because the chelate is protected, dietary inhibitors have much less impact. Calcium, polyphenols, and phytates don't bind to iron bisglycinate the way they bind to ferrous salts, which means it can be taken with food without losing meaningful absorption. For pregnant women managing first-trimester nausea, the option to take iron with breakfast rather than on an empty stomach is not a minor thing.
Third, the absorption is efficient enough that clinically meaningful doses can be much lower. A 2023 systematic review and meta-analysis of randomised trials concluded that ferrous bisglycinate raises haemoglobin and ferritin as effectively as conventional iron salts in pregnant women, while producing 64% fewer GI adverse events.
The glycine itself is a simple amino acid the body uses constantly — for collagen synthesis, neurotransmitter production, and in the synthesis of haem itself. It's a more elegant carrier than a sulfate ion.
The trade-off is cost. Chelation is a more complex manufacturing process, and iron bisglycinate typically costs three to five times more than ferrous sulfate per milligram of elemental iron. For many women, that cost reflects the price of an iron form they can actually take consistently.
| Dimension | Ferrous Sulfate | Iron Bisglycinate | Iron Polymaltose |
|---|---|---|---|
| Typical elemental dose | 65–105mg | 18–36mg | 100mg+ |
| Absorption rate | ~10–15% | Comparable or higher at lower doses in head-to-head studies | Lower than both ferrous salts and bisglycinate in head-to-head trials |
| Absorption pathway | DMT-1 (ionic) | DMT-1 + amino acid transporters (intact chelate) | Non-ionic uptake |
| GI side effects in trials | Higher — meta-analysis shows 2x odds vs placebo | Lower — comparable to placebo in several trials; 64% fewer GI events vs other iron forms in a pregnancy meta-analysis | Moderate — better tolerated than ferrous sulfate |
| Effect of food on absorption | Significantly reduced by calcium, polyphenols, phytates, tannins | Minimal — chelate is protected from dietary inhibitors | Less affected |
| Black stools (prophylactic pregnancy dose) | ~31% | ~8% | Not directly compared |
| Metallic taste | Commonly reported | Minimal | Minimal |
| Cost (Australia, indicative) | Very low ($8–$20 / month) | Moderate ($25–$45 / month) | Moderate ($20–$35 / month) |
| Evidence base | Extensive — gold standard comparator | Strong and growing, particularly in pregnancy | More limited |
The Milman trial (2014), still one of the cleanest head-to-head comparisons in pregnancy, randomised 80 Danish women to either 25mg elemental iron as ferrous bisglycinate or 50mg as ferrous sulfate from around week 16 of gestation through to delivery. At half the elemental dose, ferrous bisglycinate was non-inferior to ferrous sulfate for maintaining maternal iron status — and gastrointestinal complaints were significantly lower in the bisglycinate group (p=0.001).
A 2022 randomised controlled trial in pregnant women with low iron stores went further, showing that 24mg of iron as ferrous bisglycinate (with folinic acid) raised haemoglobin and ferritin more effectively than 66mg of ferrous fumarate, with better tolerability.
The 2015 Tolkien et al. meta-analysis in PLOS ONE — the reference most often cited when people quote ferrous sulfate side-effect rates — found ferrous sulfate roughly doubled the odds of GI side effects versus placebo, and tripled them versus IV iron. The meta-analysis found no relationship between sulfate dose and side-effect frequency. The form itself is what the research points to, not just the amount.
The newest signal: a 2025 pharmacovigilance analysis of FDA Adverse Event Reporting System (FAERS) data covering January 2000 to March 2025 examined 2,624 reports of gastrointestinal adverse events following oral iron supplementation in women with iron-deficiency anaemia. The patterns it identified reinforce what the controlled trials have been showing for over a decade: different iron forms produce different real-world tolerability signals, and the iron form is a meaningful variable in supplement choice.
Pregnancy is the life stage where iron intake matters most and where iron supplements are most often poorly tolerated. Maternal blood volume increases by roughly 50% across pregnancy. Iron requirements rise from around 0.8mg per day in the first trimester to approximately 7.5mg per day in the third, as iron is drawn into placental development, fetal growth, and the expansion of maternal red cell mass.
In Australia, the NHMRC sets the Recommended Dietary Intake (RDI) for iron in pregnancy at 27mg per day from all sources — diet plus any supplementation. Meeting that consistently through food alone is difficult, especially in the first trimester when food aversions are common, which is why oral iron supplementation is so widely used in pregnancy.
A note on dietary iron worth understanding: heme iron (from red meat, poultry, fish) is absorbed at 15–35%, while non-heme iron (from plants, fortified foods, and most supplements) is absorbed at 2–20% depending on form and dietary context. Vitamin C taken at the same time can meaningfully improve non-heme iron absorption. This is why supplement form matters more for plant-based eaters and anyone relying on supplementation as a primary iron source.
The clinical reality is that an iron supplement that triggers nausea on top of first-trimester nausea, or contributes to constipation in a body already managing pregnancy-related slowing of the gut, is an iron supplement that tends to be discontinued. The research consistently shows that lower-dose, better-tolerated iron forms support higher adherence rates.
The 2014 Milman trial captures this well. Ferrous bisglycinate at 25mg was non-inferior to ferrous sulfate at 50mg for iron status outcomes — and the women on bisglycinate had significantly fewer GI complaints, which in real-world conditions translates directly to higher daily adherence. A separate real-world analysis of over 370 pregnant women using ferrous bisglycinate found 97.6% reported no adverse events, and over 98% adhered to more than 80% of their prescribed course.
There is an emerging area of science worth understanding. When you take oral iron, it triggers a rise in hepcidin — the master regulator of iron absorption. Hepcidin stays elevated for around 24–48 hours, suppressing absorption of any iron taken in that window. The 2017 Stoffel trial in Lancet Haematology showed that taking iron daily produced worse fractional absorption than taking it every other day. Women on alternate-day dosing absorbed 21.8% of the iron, compared to 16.3% on daily dosing.
Pregnancy guidance generally still supports daily intake, particularly where iron stores are already low — the alternate-day research is most directly relevant to non-pregnant maintenance dosing. But the underlying physiology is part of why a lower elemental dose of bisglycinate — around 18–25mg — works well for many women. The dose sits within hepcidin's tolerance window, is absorbed efficiently, and is gentle enough to take consistently.
Our [INTERNAL LINK: IronBiotic product page] formulation contains iron bisglycinate at 18mg of elemental iron, paired with a Lactobacillus probiotic strain. IronBiotic is a TGA-listed (AUST L) medicine that may assist when dietary iron intake is inadequate, and may help support iron levels in the body. It is designed to work alongside our iron-free prenatal [INTERNAL LINK: EverNatal product page], which was deliberately formulated without iron so that women can manage their iron intake separately based on their own ferritin levels and tolerance. Always consult your healthcare practitioner before starting iron supplementation in pregnancy.
Iron polymaltose — sold in Australia primarily as Maltofer — is the third iron form many women have either tried or had recommended. It is a non-ionic iron complex, meaning the iron is bound up in a polysaccharide structure rather than circulating as free ferrous ions. Its GI side-effect profile is gentler than ferrous sulfate.
The trade-off is dose. Maltofer typically delivers 100mg of elemental iron per tablet, considerably more than the 18–36mg used for bisglycinate, because absorption from polymaltose is lower. Head-to-head trials in pregnant women have shown bisglycinate compares favourably to polymaltose on iron status outcomes at much lower doses.
It is a reasonable option for women who haven't tolerated ferrous sulfate and who cannot access or afford bisglycinate. It is also widely available in Australian pharmacies, which makes it easy to obtain. But where compliance and absorption efficiency are the priorities, bisglycinate has the cleaner evidence base.
Like bisglycinate, and unlike ferrous sulfate, iron polymaltose is less affected by dietary inhibitors and can be taken with meals.
Lactoferrin is a relatively new entry in oral iron supplementation worth understanding, even though it sits in a different category to the iron salts and chelates discussed above. Lactoferrin is an iron-binding glycoprotein found naturally in human and bovine milk. It supports iron transport rather than being a source of iron itself.
Several randomised trials, mostly from Egyptian and Italian research groups, have compared bovine lactoferrin to ferrous sulfate in pregnant women with iron-deficiency anaemia. Meta-analyses of this body of work have suggested daily oral lactoferrin can produce comparable iron-status improvements to ferrous sulfate with fewer gastrointestinal side effects. (One of the key trials in this area was subsequently retracted, so the evidence base needs to be read carefully.)
Lactoferrin is not currently as widely available in Australia as ferrous sulfate, bisglycinate, or polymaltose, and the evidence base is more limited and more geographically concentrated than the bisglycinate evidence. For now, ferrous bisglycinate remains the better-supported gentler alternative for most women. Lactoferrin is an area to watch as the research continues to evolve.
Most iron supplements sold in Australia fall into one of four categories. Here is how they sort, with examples:
Across the Australian market, the chelated category is where the practitioner-formulated brands tend to sit, because the evidence base for tolerability and compliance is strongest where it matters most — pregnancy and postpartum.
The right iron isn't a universal answer — it depends on your starting ferritin, your tolerance history, your pregnancy status, your budget, and your healthcare practitioner's clinical judgement. Here is the framework I use when I'm teaching women how to think about it.
If your ferritin is mildly low and you have no history of GI sensitivity: either bisglycinate or ferrous sulfate may be appropriate. Bisglycinate is the gentler option, especially if you've never supplemented before and don't know how your gut will respond.
If you've tried ferrous sulfate and stopped because of side effects: ferrous bisglycinate is worth a conversation with your healthcare practitioner. This is one of the most common scenarios in clinic, and the research supporting tolerability is strong.
If you're pregnant: discuss the right iron form with your GP, midwife, or obstetrician. The evidence supporting lower-dose bisglycinate for maintaining iron status through pregnancy and into postpartum is strong, and tolerability matters more in pregnancy than at almost any other life stage. [INTERNAL LINK: iron in pregnancy — the naturopath's complete guide] goes deeper.
If your iron levels are significantly low (ferritin below 15µg/L with low haemoglobin): this is a conversation for your GP rather than self-management. You may need higher-dose oral iron, or your doctor may recommend intravenous iron, which is widely available in Australia and corrects deficiency more rapidly than oral supplementation.
If you're on a proton pump inhibitor (PPI): mention this to your practitioner. PPIs reduce stomach acid significantly, and ferrous sulfate needs that acid to dissociate and be absorbed. Bisglycinate's absorption is largely acid-independent, which is one reason it's often preferred in this scenario.
If you're taking a prenatal multivitamin: check whether it already contains iron, and at what dose. Many prenatals — including most Australian over-the-counter options — contain iron at doses that may not match what your body actually needs. This is one of the reasons we formulated [INTERNAL LINK: EverNatal] without iron: to let women take their iron separately, at the right dose for them, with the right form for their tolerance.
The companion question is when to test. Anyone considering ongoing iron supplementation, and certainly any woman planning a pregnancy, benefits from knowing her ferritin. Medicare covers ferritin testing in Australia where clinically indicated. [INTERNAL LINK: iron blood test checklist — what to ask your GP] is the conversation guide we put together for women heading into a GP appointment.
For many women — and particularly in pregnancy — the published research supports iron bisglycinate as the more tolerable option. Iron bisglycinate is comparably effective at supporting iron status at lower elemental doses, and consistently produces fewer GI side effects in clinical trials. Ferrous sulfate retains advantages in cost and in the breadth of its research base, and remains a reasonable choice for women who tolerate it well. The case for bisglycinate is strongest where tolerability, compliance, or pregnancy is in the picture.
Across head-to-head clinical trials, iron bisglycinate consistently produces the fewest gastrointestinal side effects of the commonly used oral iron forms. In a 2024 three-way comparison in pregnant women, bisglycinate at 25mg had a lower rate of black stools (8%) than ferrous fumarate at 40mg (22%) or ferrous sulfate at 50mg (31%). Iron polymaltose and lactoferrin are also better tolerated than ferrous sulfate, though the evidence base is smaller.
Yes — you don't need to wean off one before starting the other. Many women notice an improvement in tolerability within the first week. The dose conversion is not 1:1; research suggests 18–25mg of elemental iron as bisglycinate produces comparable iron-status outcomes to 50mg as ferrous sulfate. If you're being managed for low iron levels, let your GP know you've switched so your follow-up bloods can be interpreted in that context.
It can, but at much lower rates than ferrous sulfate. In several clinical trials in pregnant women, GI side effects with bisglycinate were statistically similar to placebo. If you do experience mild constipation on bisglycinate, increasing dietary fibre, water, and considering a magnesium supplement (magnesium glycinate is gentler on the gut than other forms) usually helps. If constipation persists, speak with your healthcare practitioner.
Yes, and unlike ferrous sulfate, it can also be taken with food without losing meaningful absorption. The chelate is protected from the calcium, polyphenols, and phytates that interfere with ferrous-salt absorption. Many women find taking iron bisglycinate with breakfast easier to remember and gentler on the stomach than the empty-stomach regimen often recommended for ferrous sulfate.
Most women see measurable changes in haemoglobin within 4–8 weeks and meaningful ferritin rises within 8–12 weeks of consistent supplementation. The exact timeline depends on your starting ferritin, your iron requirements, your absorption, and whether ongoing iron losses (heavy menstrual bleeding, pregnancy demands, blood donation) are being matched by your intake. Retest at 8–12 weeks to track progress, ideally through your GP so your full iron panel can be interpreted in context.
This depends on your individual iron status and should be discussed with your GP, midwife, or obstetrician. The published clinical evidence supports 18–25mg of elemental iron per day as ferrous bisglycinate for supporting iron status in pregnancy in women whose ferritin is adequate. Higher doses may be appropriate for women with established low iron, but that's a clinical conversation based on your blood results. The Australian NHMRC RDI for iron in pregnancy is 27mg per day from all sources.
You can, but check first whether your prenatal already contains iron, and look at what other minerals are in it. Iron and calcium compete for absorption when taken together — one of the reasons we made EverNatal iron-free, so iron and calcium-containing nutrients don't have to share an absorption window. If your prenatal contains iron and you're also taking a separate iron supplement, you may be doubling up unnecessarily.
Ferrochel® is a branded, patented form of ferrous bisglycinate manufactured by Balchem (formerly Albion Minerals). Generic ferrous bisglycinate may be chemically similar but is not necessarily manufactured to the same chelation standards. Most of the well-known clinical trials in this category — including the Milman pregnancy trial — used Ferrochel or another fully-reacted bisglycinate. When comparing supplements, looking for the specific bisglycinate raw material used is one way to gauge quality.
For women with ongoing iron requirements — heavy menstrual cycles, pregnancy, postpartum, plant-based diets — bisglycinate is well tolerated long-term in the research. The important caveat for any iron supplementation, regardless of form, is that iron status should be retested periodically. Iron is one of the nutrients where more isn't always better, so the goal is to bring stores into a healthy range and maintain them — not to take iron indefinitely without review. Ongoing supplementation should be guided by your healthcare practitioner.
The best iron supplement is the one your body can absorb consistently. For many women — and particularly in pregnancy — the published research supports iron bisglycinate as the more tolerable choice.
It is not the cheapest option on the pharmacy shelf. It tends to be the one women are still taking three months in, which in iron supplementation is what matters most. An iron supplement that stays in the bottle doesn't support anyone.
If you've been working through a tablet that doesn't agree with you, the research is clear that better-tolerated, equally effective forms exist. Talk to your healthcare practitioner about whether iron bisglycinate is the right form for you.
[INTERNAL LINK: Learn more about IronBiotic — iron bisglycinate with probiotic, formulated by a naturopath for women.]
Always read the label and follow the directions for use. If symptoms persist, talk to your healthcare professional. Vitamin and mineral supplements should not replace a balanced diet.
10 min read
10 min read
Published research suggests iron bisglycinate is the best-tolerated form of iron during pregnancy. Studies show it may support iron status comparably to ferrous sulfate at roughly half the dose, with significantly fewer gastrointestinal side effects. Most pharmacy-shelf iron supplements in Australia use ferrous sulfate or ferrous fumarate — cheaper forms that commonly cause constipation and nausea.
